300725 药石科技
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.1927.5457.19012.35922.515
总资产报酬率 ROA (%)1.3864.3743.9617.50916.404
投入资产回报率 ROIC (%)1.4874.7394.3068.45218.703

边际利润分析
销售毛利率 (%)31.04638.05542.51945.47648.125
营业利润率 (%)9.49914.87610.70018.60641.024
息税前利润/营业总收入 (%)11.41016.41515.97920.15443.617
净利润/营业总收入 (%)7.88313.00111.44020.43641.924

收益指标分析
经营活动净收益/利润总额(%)104.34999.102107.50692.30252.191
价值变动净收益/利润总额(%)12.31617.999-4.5054.52347.231
营业外收支净额/利润总额(%)-1.273-0.92816.6128.2162.917

偿债能力分析
流动比率 (X)3.9503.6262.6683.5982.287
速动比率 (X)2.8922.5051.9822.6831.719
资产负债率 (%)34.35639.46544.50945.34125.071
带息债务/全部投入资本 (%)29.18732.50938.52038.41416.915
股东权益/带息债务 (%)238.091202.722155.374156.037478.035
股东权益/负债合计 (%)191.071153.387124.674120.552276.092
利息保障倍数 (X)5.6219.7955.077-171.42732.068

营运能力分析
应收账款周转天数 (天)76.376101.84583.86859.99055.178
存货周转天数 (天)221.913269.301254.331232.755218.761